EDAP TMS S.A. - American Depositary Shares, each representing One Ordinary Share (FOCL)

HIFU revenue surged 39% as system sales jumped 44%, signaling strong adoption momentum.

FocalTherics (NASDAQ:FOCL) reported second-quarter HIFU revenue of $13.2 million, up 39% from $9.5 million a year earlier, as the company continued to expand sales of its Focal One high-intensity focused ultrasound platform for focal therapy. Chief Executive Officer Ryan Rhodes characterized the pe

Edap TMS (NASDAQ:FOCL) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This content is powered by Benzinga APIs. For

39% Revenue Increase and 47% Growth in U.S. Procedures

FocalTherics™ Announces Pricing of Public Offering of American Depositary Shares

FocalTherics™ Reports Preliminary Financial Results for Second Quarter of 2026

FocalTherics™ Announces Proposed Public Offering of American Depositary Shares

Company to host conference call and webcast on Thursday, August 13 at 4:30 p.m. EDT

FocalTherics™ Announces Successful Launch of First Commercial Endometriosis Focal One® Program in Europe with Treatment of Initial Patients

FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical